# Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

> **NCT01687296** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 261 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone propionate inhalation solution
- **DRUG:** oral prednisone
- **DRUG:** placebo inhalation solution
- **DRUG:** placebo tablet
- **DRUG:** salbutamol

## Key facts

- **NCT ID:** NCT01687296
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-12
- **Primary completion:** 2013-06-01
- **Final completion:** 2013-06-21
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687296, "Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01687296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*